Primary and secondary prevention of heart disease: can we curb the global epidemic?
作者信息
Smith S C
机构信息
Division of Cardiology, Center for Cardiovascular Science and Medicine, University of North Carolina at Chapel Hill, USA.
出版信息
Trans Am Clin Climatol Assoc. 2001;112:89-95; discussion 95-8.
Abstract
摘要
相似文献
1
Primary and secondary prevention of heart disease: can we curb the global epidemic?心脏病的一级和二级预防：我们能否遏制这一全球流行病？
Trans Am Clin Climatol Assoc. 2001;112:89-95; discussion 95-8.
2
Women and heart disease: what's new?女性与心脏病：有哪些新情况？
Nursing. 2007 Fall;37 Suppl Cardiac:8-13. doi: 10.1097/01.NURSE.0000294285.26047.eb.
3
Guidelines update on the prevention of heart disease in women.女性心脏病预防指南更新
J Am Acad Nurse Pract. 2008 Apr;20(4):191-3. doi: 10.1111/j.1745-7599.2008.00309.x.
4
The heart truth about heart disease and risk factors.关于心脏病及风险因素的核心真相。
Pa Nurse. 2005 Mar;60(2):33-4.
5
Raising awareness of women and heart disease--women's hearts are different.提高对女性与心脏病的认识——女性的心脏有所不同。
Crit Care Nurs Clin North Am. 2008 Sep;20(3):251-63. doi: 10.1016/j.ccell.2008.03.002.
6
Patient handout. The heart truth for women. What women need to know about heart disease.患者手册。女性的心脏真相。女性需要了解的心脏病知识。
Geriatrics. 2003 Dec;58(12):26-8.
7
[Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].[动脉粥样硬化的一级和二级预防。高血压的风险分层]
Z Kardiol. 2002 Oct;91(10):777-85. doi: 10.1007/s00392-002-0842-y.
8
Women's risk of heart disease: promoting awareness and prevention--a primary care approach.女性心脏病风险：提高认识与预防——一种初级保健方法
Medsurg Nurs. 2008 Apr;17(2):107-13.
9
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group II: age-dependent risk factors for obesity and comorbidities.第七届预防会议：肥胖，一种与心脏病和中风相关的全球流行病：第二组：肥胖及合并症的年龄依赖性风险因素
Circulation. 2004 Nov 2;110(18):e471-5. doi: 10.1161/01.CIR.0000140092.48032.D2.
10
Benefits of risk factor modification through cardiac rehabilitation.通过心脏康复改善风险因素的益处。
Bol Asoc Med P R. 2008 Oct-Dec;100(4):75-9.
引用本文的文献
1
Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.结构型apelin类似物：心肌缺血再灌注损伤中的线粒体活性氧抑制及心脏代谢保护作用
Br J Pharmacol. 2015 Jun;172(12):2933-45. doi: 10.1111/bph.13038. Epub 2015 Apr 23.
本文引用的文献
1
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.脂质治疗评估项目（L-TAP）：一项多中心调查，旨在评估接受降脂治疗并达到低密度脂蛋白胆固醇目标的血脂异常患者的百分比。
Arch Intern Med. 2000 Feb 28;160(4):459-67. doi: 10.1001/archinte.160.4.459.
2
Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement.女性预防性心脏病学指南。美国心脏协会/美国心脏病学会科学声明共识小组声明。
Circulation. 1999 May 11;99(18):2480-4. doi: 10.1161/01.cir.99.18.2480.
3
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.急性心肌梗死治疗的地域差异：合作心血管项目
JAMA. 1999 Feb 17;281(7):627-33. doi: 10.1001/jama.281.7.627.
4
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防：空军/德州冠状动脉粥样硬化预防研究（AFCAPS/TexCAPS）的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
5
6
Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action.
Circulation. 1998 Feb 17;97(6):602-4. doi: 10.1161/01.cir.97.6.602.
7
The epidemic of cardiovascular disease in Eastern Europe.东欧的心血管疾病流行情况。
N Engl J Med. 1997 Jun 26;336(26):1915-6. doi: 10.1056/NEJM199706263362614.
8
The challenge of risk reduction therapy for cardiovascular disease.
Am Fam Physician. 1997 Feb 1;55(2):491-500.
9
Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California.
Circulation. 1996 Jun 15;93(12):2205-11. doi: 10.1161/01.cir.93.12.2205.
10
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.普伐他汀对胆固醇水平正常的心肌梗死患者冠状动脉事件的影响。胆固醇与再发事件试验研究人员。
N Engl J Med. 1996 Oct 3;335(14):1001-9. doi: 10.1056/NEJM199610033351401.
Zotero 插件